Skip to main content

Market Overview

Alcon, Inc.Acquires LenSx, Still In Negotiations With Novartis (ACL, NVS)

Share:

Alcon Inc. (NYSE: ACL) has signed an agreement to acquire LenSx Laser for $744 million. Alcon is a specialty company focused primarily on eye care; the company produces pharmaceuticals, surgical equipment, and consumer eye care products.

Jefferies analysts Joshua Jennings and Anthony Petrone believe this acquisition makes strategic sense. 82% of Alcon's surgical revenues came from the surgical cataract market, so this acquisition is no surprise.

Given the recent U.S. approval of femtosecond lasers, LenSx is well positioned tap into this market.

Alcon is currently in merger negotiations with Novartis (NYSE: NVS)(ADR). Jefferies does not Novartis to block this acquisition, as it allows Novartis to establish a presence in the surgical ophthalmic market.

Alcon is currently rated Buy with a price target of $170.00. Shares of ACL are currently trading at $149.92.

Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free.

 

Related Articles (ACL + NVS)

View Comments and Join the Discussion!

Posted-In: Anthony Petrone Jefferies Joshua JenningsAnalyst Color Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com